Dennis K. Burns, MD, Southwestern Medical School 1978

Affiliations: 
Pathology University of Texas Southwestern Medical Center, Dallas, TX, United States 
Website:
http://www.utsouthwestern.edu/findfac/professional/0,,10983,00.html
Google:
"Dennis Burns"
Mean distance: 18.08 (cluster 32)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chkheidze R, Cimino PJ, Hatanpaa KJ, et al. (2019) Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas. Journal of Neuropathology and Experimental Neurology
Richardson TE, Wachsmann M, Oliver D, et al. (2018) BRAF mutation leading to central nervous system Rosai-Dorfman disease. Annals of Neurology
Yell PC, Burns DK, Dittmar EG, et al. (2018) Diffuse microvascular C5b-9 deposition is a common feature in muscle and nerve biopsies from diabetic patients. Acta Neuropathologica Communications. 6: 11
Richardson TE, Shen ZJ, Kanchwala M, et al. (2017) Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis. Journal of Neuropathology and Experimental Neurology. 76: 874-882
Chkheidze R, Burns DK, White CL, et al. (2017) Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity. Journal of Neuropathology and Experimental Neurology
Georgescu MM, Pinho Mda C, Richardson TE, et al. (2015) The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease. Acta Neuropathologica Communications. 3: 81
Richardson TE, Mathis DA, Mickey BE, et al. (2015) Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry. Journal of Neuropathology and Experimental Neurology. 74: 1170-1177
Alcantara Llaguno SR, Wang Z, Sun D, et al. (2015) Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. Cancer Cell. 28: 429-40
Malafronte PJ, LePage EM, Hatanpaa KJ, et al. (2014) Expression of MAP 2 by haemangioblastomas: an immunohistochemical study with implications for diagnosis. Pathology. 46: 450-1
Hatanpaa KJ, Hu T, Vemireddy V, et al. (2014) High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas. Journal of Neuro-Oncology. 117: 183-9
See more...